Blockchain Registration Transaction Record

ADAP Advocacy Urges CMS to Exclude HIV Meds from Drug Price Negotiations

ADAP Advocacy calls for HIV medication carve-out in Medicare drug price negotiations, emphasizing risks to PLWHA and the importance of treatment access.

This news is crucial because it addresses the potential risks to the health and well-being of People Living with HIV/AIDS if their medications become part of Medicare's drug price negotiation program. Access to consistent and effective treatment is vital for managing HIV, preventing the virus from developing resistance, and reducing the spread of new infections. The advocacy's efforts highlight the broader implications of healthcare policy on vulnerable populations and the importance of safeguarding access to life-saving medications.